All In MedTech

PMA device

OPTIMIZER Smart System

Impulse Dynamics (Usa), Inc. · Implantable Pulse Generator (QFV, Class III) · First FDA decision Mar 21, 2019, newest Jul 15, 2025Heart failure

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

11

PMA pathway

Device trials

8

Naming "OPTIMIZER Smart"

MAUDE reports

167

Brand "OPTIMIZER Smart", since 2015

PubMed studies

14

Mentioning "OPTIMIZER Smart"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing OPTIMIZER Smart System

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology, with pictures of the device
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 6 of 11 decisions filed under this name.

5 more FDA decisions with a free account

Older decisions: P180036-S008, P180036-S006, P180036-S005, P180036-S003, P180036

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "OPTIMIZER Smart", any status and sponsor, newest update first.

Open in Trial Radar
  • Impulse DynamicsNot on our public-company list

    NCT05064709 · 1,500 participants (planned) · Start Feb 3, 2022 · Primary completion Feb 1, 2029

    Device: Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System; OPTIMIZER™ Smart Mini System · For: Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction and 2 more

    Sites: Birmingham, Alabama; Mesa, Arizona; Scottsdale, Arizona · 67 sites in all

7 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "OPTIMIZER Smart", and for the whole product code for context.

This brand

167 reports: 56 malfunction, 108 injury, 3 death

Whole product code QFV

183 reports: 61 malfunction, 119 injury, 3 death

Newest reports for this brand

4 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recall in FDA's data is linked to these FDA numbers.

Published research

The most relevant PubMed records for "OPTIMIZER Smart"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code QFV.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.